|
⚲
|
| Stemline Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001264587 |
| Sale | 2010-03-16 ($1.2 M Offered, $1.2 M Sold) |
| Fund | |
| Phone | 2125315969 |
| Address | 1675 York Avenue, Suite 34L New York, 10128 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Ronald Bentsur | |
| Ivan Bergstein |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
KN Fund I, a series of Bee Partners SPV, LP
✚
|
0.0 | |
|
SMX (Security Matters) Public Ltd Co
✚
|
0.0 | |
|
KN Fund I, a series of Syncopation Funds, LP
✚
|
0.0 | |
|
SN-05271 Fund I, a series of Roll Up Vehicles, LP
✚
|
0.0 | |
|
Snabe Jim H.
✚
|
0.0 | |
|
Snacking Investments HoldCo Pty Ltd
✚
|
0.0 | |
|
SNAF New England, LLC
✚
|
0.0 | |
|
Smyth Gerard P.
✚
|
0.0 | |
|
Serra Tanguy
✚
|
0.0 | |
|
New Residential Investment Corp.
✚
|
0.0 |